Wilms' Tumor
What's New
Last Posted: Feb 28, 2023
- Development of a Machine Learning-Based Prediction Model for Chemotherapy-Induced Myelosuppression in Children with Wilms' Tumor.
Mujie Li et al. Cancers 2023 15(4) - Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort: A Comprehensive Clinical and Genomic Characterization.
Hol Janna A et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 JCO2102510 - Results From the WAGR Syndrome Patient Registry: Characterization of WAGR Spectrum and Recommendations for Care Management.
Duffy Kelly A et al. Frontiers in pediatrics 2021 9733018 - Comprehensive Biology and Genetics Compendium of Wilms Tumor Cell Lines with Different WT1 Mutations.
Royer-Pokora Brigitte et al. Cancers 2020 Dec 13(1) - Early diagnosis of WT1 nephropathy and follow up in a Chinese multicenter cohort.
Sun Shuzhen et al. European journal of medical genetics 2020 Sep 104047 - Surrogate-free machine learning-based organ dose reconstruction for pediatric abdominal radiotherapy.
Virgolin Marco et al. Physics in medicine and biology 2020 Jun - Molecular diagnostics of disorders of sexual development: an Indian survey and systems biology perspective.
Nagaraja M R et al. Systems biology in reproductive medicine 2019 Apr 65(2) 105-120 - NCCN Releases Clinical Practice Guidelines for Pediatric ALL,
by Allison Inserro, AJMC, May 30, 2019 - Measurable residual disease monitoring using Wilms tumor gene 1 expression in childhood acute myeloid leukemia based on child-specific reference values.
Løvvik Juul-Dam Kristian et al. Pediatric blood & cancer 2019 Mar e27671 - Management of Denys-Drash syndrome: A case series based on an international survey.
Gariépy-Assal Laurence et al. Clinical nephrology. Case studies 2018 636-44
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 30, 2024
- Content source: